Analyzing Nanovibronix (FEED) and Its Competitors

Nanovibronix (NASDAQ:FEED) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Nanovibronix to similar companies based on the strength of its valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

Institutional and Insider Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 12.2% of Nanovibronix shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Nanovibronix and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	4237	10435	18122	818	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 24.91%. Given Nanovibronix’s peers stronger consensus rating and higher probable upside, analysts plainly believe Nanovibronix has less favorable growth aspects than its peers.

Volatility & Risk

Nanovibronix has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, Nanovibronix’s peers have a beta of 1.43, meaning that their average share price is 43% more volatile than the S&P 500.

Valuation and Earnings

This table compares Nanovibronix and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$1.93 million	-$18.18 million	-0.00
Nanovibronix Competitors	$840.40 million	$55.25 million	11.29

Nanovibronix’s peers have higher revenue and earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Nanovibronix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-1,093.61%	-60.73%	-48.48%
Nanovibronix Competitors	-367.60%	-172.56%	-24.30%

Summary

Nanovibronix peers beat Nanovibronix on 11 of the 13 factors compared.

Nanovibronix Company Profile

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.